Direct Rx FDA Record
- Latest inspection NAI · Jun 4, 2026
- No warning letters matched by name
Direct Rx has 38 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Direct Rx" is on file.
- Latest recall
- D-0107-2027 · Class II · Sep 29, 2026
- Latest inspection
- Jun 4, 2026 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 38 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Direct Rx: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 2 | 0 |
| 2025 | 0 | 0 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 1 | 0 |
| 2023 | 0 | 0 | 0 | 14 | 0 |
| 2022 | 0 | 0 | 0 | 10 | 0 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 0 | 3 | 0 |
| 2019 | 0 | 0 | 0 | 2 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Direct Rx as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Direct Rx yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0107-2027 | Class II | Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville… | Sep 29, 2026 |
| D-0617-2026 | Class II | DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps… | Jun 22, 2026 |
| D-0567-2025 | Class II | Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx… | Mar 7, 2025 |
| D-0568-2025 | Class II | Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b)… | Mar 7, 2025 |
| D-0364-2025 | Class II | CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and… | Jan 31, 2025 |
| D-0041-2025 | Class II | Ibuprofen 800mg, Generic for: Motrin, Each tablet contains: Ibuprofen, USP 800 mg, Packaged and… | Aug 9, 2024 |
| D-0509-2023 | Class II | Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx… | Mar 22, 2023 |
| D-0507-2023 | Class II | Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx… | Mar 22, 2023 |
| D-0508-2023 | Class II | Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle… | Mar 22, 2023 |
| D-0480-2023 | Class II | Glimepiride, USP, 1 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0723-30; b)… | Mar 13, 2023 |
| D-0484-2023 | Class II | Simvastatin, USP, 10 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0688-30 b)… | Mar 13, 2023 |
| D-0479-2023 | Class II | Ropinirole, USP, 1 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged… | Mar 13, 2023 |
| D-0477-2023 | Class II | Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged… | Mar 13, 2023 |
| D-0483-2023 | Class II | Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged… | Mar 13, 2023 |
| D-0478-2023 | Class II | Ropinirole, USP, 0.25 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30… | Mar 13, 2023 |
| D-0486-2023 | Class II | Simvastatin, USP, 40 mg, Rx Only, Packaged as a 90-count bottle, NDC 61919-0431-90, Packaged and… | Mar 13, 2023 |
| D-0481-2023 | Class II | Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b)… | Mar 13, 2023 |
| D-0482-2023 | Class II | Glimepiride, USP, 4 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0250-30; b)… | Mar 13, 2023 |
| D-0485-2023 | Class II | Simvastatin, USP, 20 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0446-30 b)… | Mar 13, 2023 |
| D-0476-2023 | Class II | Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC… | Mar 13, 2023 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 4, 2026 | Dawsonville, GA | Drugs | No Action Indicated (NAI) | 3011690045 |
| Dec 15, 2017 | Dawsonville, GA | Drugs | No Action Indicated (NAI) | 3011690045 |
| Aug 13, 2015 | Dawsonville, GA | Drugs | Voluntary Action Indicated (VAI) | 3011690045 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3011690045 | Dawsonville, GA | 3 | Jun 4, 2026 |
Direct Rx and the FDA: common questions
Has Direct Rx received an FDA warning letter?
No FDA warning letter addressed to the name "Direct Rx" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Direct Rx received an FDA Form 483?
FDA has not published a Form 483 for "Direct Rx" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Direct Rx?
The most recent FDA inspection on file ended Jun 4, 2026 at Dawsonville, GA and was classified NAI. FDA has 3 inspections of Direct Rx on file.
Has Direct Rx had an FDA recall?
Yes. Direct Rx has 38 FDA recalls on record. The most recent started Sep 29, 2026.
Need more than this page shows? Ask about Direct Rx in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.